SLC/CCL21-mediated anti-tumor responses require IFNγ, MIG/CXCL9 and IP-10/CXCL10

Overview of attention for article published in Molecular Cancer, April 2003

Altmetric Badge

Citations

dimensions_citation: 74 Dimensions

Readers on

mendeley: 20 Mendeley

Summary Dimensions citations

So far, Dimensions has found 74 publications that cite this research output.

74

The most recent citing publications are shown below. View all 74 publications that cite this research output on Dimensions.

CXCL9/10-engineered dendritic cells promote T cell activation and enhance immune checkpoint blockade for lung cancer

Article in Cell Reports Medicine (March 2024)

CCL21-DC in situ vaccination in murine NSCLC overcomes resistance to immunotherapy and generates systemic tumor-specific immunity

Article in Journal for ImmunoTherapy of Cancer (September 2023)

Nonclassical monocytes potentiate anti-tumoral CD8+ T cell responses in the lungs

Article in Frontiers in Immunology (June 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.